SDPS-09 MIXED RESPONSE OF BRAIN METASTASES TREATED WITH OSIMERTINIB PREDICTS INFERIOR SURVIVAL OUTCOMES: AN ARTIFICIAL INTELLIGENCE-BASED LESION-LEVEL ASSESSMENT FOR CRANIAL CONTROL OF EGFRMUTANT NONSMALL CELL LUNG CANCER

Osimertinib has been found to be effective for intracranial control in patients with metastatic EGFR-mutant non-small cell lung cancer (NSCLC). However, the lesion-level response of brain metastases to osimertinib has not been thoroughly evaluated. This retrospective study included 73 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Shao-Lun, Chang, Yu-Cheng, Hui, Caressa, Liang, Chih-Hung, Chiang, Po-Lin, Lin, Vicki, Lu, Jen-Tang, Pollom, Erqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Screening/Diagnostics/Prognostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402388/
http://dx.doi.org/10.1093/noajnl/vdad070.069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402388/
http://dx.doi.org/10.1093/noajnl/vdad070.069

Ejemplares similares